MedPath

The effect of aromatherapy with essential oil of lavender on anxiety

Phase 2
Conditions
Anxiety.
Generalized anxiety disorder
Registration Number
IRCT2016060826136N1
Lead Sponsor
Vice chancellor for research Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
100
Inclusion Criteria

having age more than 18 years; earn a higher score of 20 after responding to a questionnaire STAI (minimum score of 20 and higher than 20 can show the impact of the intervention); the ability to understand and speak Persian; ability to read and write; the absence of olfactory dysfunction; lack of mental illness. Exclusion criteria: acute pain at the time of completing the questionnaire; the use of benzodiazepines; tranquilizers and drugs psychiatric drugs; a history of eczema and allergies to plants, allergic rhinitis and asthma; history of migraine and headache; drug addiction (alcohol and cigarettes); lack of participation and the willingness of patients to withdraw from the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety Intensity. Timepoint: Preintervention and 25 min after intervention. Method of measurement: Spielberger State Anxiety Inventory.
Secondary Outcome Measures
NameTimeMethod
Blood Presure. Timepoint: Pre intervention and 25 min after intervention. Method of measurement: Mercury blood pressure devices (Richter).;Palse. Timepoint: Pre intervention and 25 min after intervention. Method of measurement: According to minutes using the pulse oximetry finger.;Breathing. Timepoint: Pre intervention and 25 min after intervention. Method of measurement: According to minutes using the standard digital clock.
© Copyright 2025. All Rights Reserved by MedPath